We are live on ! Find out more
AI

ArchPoint Investors Portfolio holdings

AUM $420M
1-Year Est. Return 42.19%
This Fund
S&P 500
This Quarter Est. Return
+5.21%
1 Year Est. Return
+42.19%
3 Year Est. Return
+98.24%
5 Year Est. Return
+100.5%
10 Year Est. Return
+371.01%
AUM
$314M
AUM Growth
-$23K
Cap. Flow
-$9.34M
Cap. Flow %
-2.97%
Top 10 Hldgs %
61.5%
Holding
166
New
13
Increased
59
Reduced
18
Closed
13

Sector Composition

Rank Sector Weight
1 Communication Services 38.89%
2 Consumer Discretionary 9.46%
3 Healthcare 8.97%
4 Energy 8.26%
5 Real Estate 5.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAR icon
151
Avis
CAR
$4.86B
-2,000
Closed -$55K
GE icon
152
GE Aerospace
GE
$374B
-22,995
Closed -$3M
MDY icon
153
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
-6,060
Closed -$1.93M
MO icon
154
Altria Group
MO
$114B
-61,916
Closed -$4.65M
PEG icon
155
Public Service Enterprise Group
PEG
$38.2B
-11,630
Closed -$500K
QID icon
156
ProShares UltraShort QQQ
QID
$282M
-31
Closed -$44K
THC icon
157
Tenet Healthcare
THC
$20.5B
-5,000
Closed -$97K
TVTX icon
158
Travere Therapeutics
TVTX
$5.2B
-2,500
Closed -$48K
AVXS
159
DELISTED
AveXis, Inc. Common Stock
AVXS
-1,500
Closed -$135K
RAI
160
DELISTED
Reynolds American Inc
RAI
-29,771
Closed -$1.95M
OKS
161
DELISTED
Oneok Partners LP
OKS
-13,906
Closed -$710K
ATVI
162
PUT
DELISTED
Activision Blizzard
ATVI
-41,710
Closed -$122K

Similar funds

ArchPoint Investors's Q3 2017 Portfolio in Review

As of Q3 2017, ArchPoint Investors held 166 positions worth $314M, down 0.01% from $314M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

ArchPoint Investors's Q3 2017 filing shows 13 new, 59 increased, 18 reduced and 13 closed positions. Its largest new stake was Vertex Pharmaceuticals: 9,991 shares worth $1.52M. The largest sale was Altria Group, an estimated $4.65M.

By sector, the portfolio is most concentrated in Communication Services at 39% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • ArchPoint Investors's largest Q3 2017 buy was Vertex Pharmaceuticals: 9,991 shares worth $1.52M.
  • ArchPoint Investors added most to Amazon in Q3 2017, an estimated $1.51M increase.
  • ArchPoint Investors's biggest Q3 2017 reduction was SPDR Gold Trust, cutting an estimated $4.52M.
  • ArchPoint Investors fully exited Altria Group in Q3 2017, selling an estimated $4.65M.
  • ArchPoint Investors's ten largest holdings make up 62% of its $314M portfolio in Q3 2017.
  • ArchPoint Investors opened 13 new positions and closed 13 in Q3 2017.
  • ArchPoint Investors's portfolio value fell 0.01% quarter-over-quarter to $314M.

Based on ArchPoint Investors's 13F filing for Q3 2017, filed 14 Nov 2017.